Medintech Europas - Company finances
|
EUR
|
2021
From: 2021-04-20
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | 10,402 | 5,567 | 164,525 | 262,944 | 715,856 |
| Profit before tax | 1,508 | 1,728 | 32,253 | 46,319 | 22,924 |
| Net profit | 1,508 | 1,642 | 26,915 | 43,875 | 17,805 |
| Equity | 4,008 | 5,650 | 32,565 | 76,440 | 76,980 |
| Liabilities | 82,170 | 79,665 | 389,284 | 186,033 | 266,062 |
| Non-current assets | 0 | 0 | 0 | 32,638 | 0 |
| Current assets | 86,178 | 85,315 | 421,849 | 229,835 | 343,027 |
| Total assets | 86,178 | 85,315 | 421,849 | 262,473 | 343,027 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | -46.5% | +2855.4% | +59.8% | +172.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 1.7% | 1.9% | 6.4% | 16.7% | 5.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 37.6% | 29.1% | 82.7% | 57.4% | 23.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 14.5% | 29.5% | 16.4% | 16.7% | 2.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 14.5% | 31.0% | 19.6% | 17.6% | 3.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 20.5 | 14.1 | 12.0 | 2.4 | 3.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 5,548 | 3,093 | 139,216 | 131,472 | 357,928 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medintech Europas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-27 | 2026-08-30 | 274.97 |
| 2026-08-26 | 2026-08-26 | 281.21 |
| 2026-08-23 | 2026-08-23 | 281.21 |
| 2026-08-19 | 2026-08-19 | 281.21 |
| 2026-08-16 | 2026-08-17 | 35.97 |
| 2026-07-27 | 2026-08-14 | 35.97 |
| 2026-07-26 | 2026-07-26 | 35.48 |
| 2026-07-23 | 2026-07-25 | 35.97 |
| 2026-07-19 | 2026-07-22 | 35.48 |
| 2026-07-16 | 2026-07-17 | 35.48 |
| 2026-06-16 | 2026-06-24 | 215.78 |
| 2026-01-16 | 2026-01-19 | 307.50 |
| 2025-04-16 | 2025-04-16 | 207.26 |
| 2024-05-16 | 2024-05-22 | 290.65 |
| 2023-11-16 | 2023-11-16 | 98.17 |
| 2023-07-24 | 2023-08-16 | 0.03 |
| 2023-07-18 | 2023-07-20 | 1.07 |
| 2023-06-16 | 2023-07-10 | 1.07 |
| 2023-05-16 | 2023-06-13 | 1.07 |
| 2023-05-02 | 2023-05-08 | 1.07 |
| 2023-04-25 | 2023-04-28 | 1.07 |
| 2023-04-18 | 2023-04-24 | 0.94 |
| 2023-03-23 | 2023-04-06 | 0.95 |
| 2023-03-16 | 2023-03-22 | 56.29 |
| 2023-02-06 | 2023-03-15 | 0.95 |
| 2022-12-14 | 2023-02-03 | 0.95 |
| 2022-11-21 | 2022-12-13 | 4.06 |
| 2022-10-31 | 2022-11-18 | 4.06 |
| 2022-09-29 | 2022-10-30 | 3.11 |
| 2022-08-10 | 2022-09-28 | 5.33 |
| 2022-07-25 | 2022-08-09 | 124.93 |
| 2022-07-14 | 2022-07-24 | 120.66 |
| 2022-07-11 | 2022-07-13 | 139.62 |
| 2022-06-23 | 2022-07-10 | 152.77 |
| 2022-06-20 | 2022-06-22 | 171.73 |
| 2022-06-16 | 2022-06-19 | 190.69 |
| 2022-06-09 | 2022-06-15 | 189.63 |
| 2022-05-26 | 2022-06-08 | 203.61 |
| 2022-05-17 | 2022-05-25 | 218.22 |
| 2022-04-25 | 2022-05-16 | 109.00 |
| 2022-04-19 | 2022-04-24 | 108.89 |
| 2022-03-16 | 2022-03-17 | 109.67 |
| 2022-02-17 | 2022-03-15 | 0.45 |
| 2022-01-27 | 2022-02-14 | 0.45 |
| 2022-01-18 | 2022-01-26 | 0.26 |
| 2021-11-09 | 2022-01-17 | 0.27 |
| 2021-09-20 | 2021-11-08 | 0.10 |
| 2021-09-16 | 2021-09-19 | 145.72 |
Medintech Europas - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medintech Europas, UAB (company code 305737812) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, revenue increased sharply to €715.9K from €262.9K in 2024 and €164.5K in 2023, showing strong top-line expansion over the last two years. Net profit, however, declined to €17.8K in 2025 from €43.9K in 2024 and €26.9K in 2023, as profitability weakened. The net profit margin fell to 2.5% in 2025, compared with 16.7% in 2024 and 16.4% in 2023. At year-end 2025, total assets stood at €343.0K, equity at €77.0K and liabilities at €266.1K. The equity ratio was 22.4%, while debt-to-equity reached 3.46. Asset turnover was 2.09x, indicating efficient use of assets in generating sales. Return on equity was 23.1% and return on assets 5.2%. Revenue per employee was €357.9K, with profit per employee of €8.9K.